Similar Articles

Genetically engineered mice models and generating glioblastoma multiforme in the brain

Yasin Polat, Oytun Erbaş

DOI: 10.5606/fng.btd.2024.147

Issue: 2024, Volume 10 - Issue 1
3075 2039

Balancing Act: NRF2's contradictory roles in cancer progression and therapy

Alper Demirezen, Oytun Erbaş

DOI: 10.5606/fng.btd.2024.160

Issue: 2024, Volume 10 - Issue 3
6757 1314

Microbial influences on cancer: Mechanisms and implications

Gökçen Kılınç, Oytun Erbaş

DOI: 10.5606/fng.btd.2024.161

Issue: 2024, Volume 10 - Issue 3
3409 1149

Expression profiles and regulatory crosstalk of lncRNA HOTAIR and miR-29b-3p across breast cancer subtypes: Implications for tumor progression and therapy resistance

Şara Alagöz, Şehnaz Doğa Kök

DOI: 10.5606/fng.btd.2025.189

Issue: 2025, Volume 11 - Issue 2
1056 771

The ZEB1-AS1/ZEB1 axis promotes epithelial-mesenchymal transition in prostate cancer

Gamze Nur Öter, Merve Nur Işık Kolukısaoğlu, İlknur Bingül, Servet Tunoğlu, Canan Küçükgergin

DOI: 10.5606/fng.btd.2025.192

Issue: 2025, Volume 11 - Issue 2
734 656

The role of mesenchymal stem cell exosomes in cancer biology

Alper Demirezen

DOI: 10.5606/fng.btd.2025.186

Issue: 2025, Volume 11 - Issue 2
849 660

Subtype-specific lncRNA signatures: MALAT1 and XIST in breast cancer

Pelin Soytürk, Miray Acer

DOI: 10.5606/fng.btd.2025.206

Issue: 2025, Volume 11 - Issue 3
130 159

Exosomes in cancer progression: Orchestrators of EMT, pre-metastatic niches, and therapy resistance

Irem Yalim Camci, Arzu Aysan, Nursah Ersezen, Iremnur Caglayan

DOI: 10.5606/fng.btd.2025.199

Issue: 2025, Volume 11 - Issue 3
110 128